A Phase I, Open-Labeled, Single-Arm, Dose Escalation, Clinical and Pharmacology Study of Dichloroacetate (DCA) in Patients With Recurrent and/or Metastatic Solid Tumours.
Latest Information Update: 14 Mar 2016
At a glance
- Drugs Sodium dichloroacetate (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 10 Mar 2016 Status changed from active, no longer recruiting to completed.as reported by ClinicalTrials.gov.
- 10 Mar 2016 Status changed from active, no longer recruiting to completed.as reported by ClinicalTrials.gov.
- 18 Nov 2013 Planned end date changed from 1 May 2012 to 1 Jan 2014 as reported by ClinicalTrials.gov.